|
Name of the product: ALLOPURINOL DOSA (*)
Active ingredient: Allopurinol 500 mg (as allupourinol sodium)
Dosage form: lyophilised injection
Dispensing requirements: Rx only
Argentine Industry
Composition:
Each glass bottle with lyophilised injection contains allopurinol 500 mg (as allopurinol sodium) and mannitol.
Each glass bottle with dissolving solution contains water for injection.
Indications:
ALLOPURINOL DOSA is indicated for the treatment of patients with leukaemia, lymphoma and solid tumour malignancies when concurrently receiving cancer therapy that causes elevation of serum and urinary uric acid levels and who cannot tolerate oral therapy.
Therapeutic action:
Antihyperuricaemic.
Storage:
Keep at temperature below 25º C, in the marketed packing.
Marketed presentations:
Packs containing 1 glass bottle with lyophilised injection + 1 glass bottle with dissolving solution.
Packs containing 50 glass bottles with lyophilised injection + 50 glass bottles with dissolving solution, four use in hospitals.
Medicinal speciality authorised by the Ministry of Health.
Certificate Nº 51.026
Laboratorio DOSA S.A.
Girardot 1369, (C1427AKC) Buenos Aires, Argentine
Pharmaceutical Director: María C. Terzo, Pharmacist
|
